Chasing the last cancer cell: can a transplant lock in remission for amyloidosis?
NCT ID NCT07215494
Summary
This study aims to see if a stem cell transplant can help patients with AL amyloidosis who have responded well to initial drug therapy but still have tiny amounts of disease left. Researchers will first check 50 patients for this 'minimal residual disease' (MRD) after drug treatment. For those who test positive and are eligible, they will then see if adding a transplant leads to better organ recovery and longer survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIGHT CHAIN (AL) AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.